• Subscribe
  • Magazines
  • About
  • Contact
  • Advertise
Friday 9 May 2025
  • zh-hant 中文
  • ja 日本語
  • en English
IAG
Advertisement
  • Newsfeed
  • Mag Articles
  • Video
  • Opinion
  • Tags
  • Regional
    • Africa
    • Australia
    • Cambodia
    • China
    • CNMI
    • Europe
    • Hong Kong
    • India
    • Japan
    • Laos
    • Latin America
    • Malaysia
    • Macau
    • Nepal
    • New Zealand
    • North America
    • North Korea
    • Philippines
    • Russia
    • Singapore
    • South Korea
    • Sri Lanka
    • Thailand
    • UAE
    • Vietnam
  • Events
  • Contributors
  • SUBSCRIBE FREE
  • 中文
  • 日本語
No Result
View All Result
IAG
  • Newsfeed
  • Mag Articles
  • Video
  • Opinion
  • Tags
  • Regional
    • Africa
    • Australia
    • Cambodia
    • China
    • CNMI
    • Europe
    • Hong Kong
    • India
    • Japan
    • Laos
    • Latin America
    • Malaysia
    • Macau
    • Nepal
    • New Zealand
    • North America
    • North Korea
    • Philippines
    • Russia
    • Singapore
    • South Korea
    • Sri Lanka
    • Thailand
    • UAE
    • Vietnam
  • Events
  • Contributors
  • SUBSCRIBE FREE
  • 中文
  • 日本語
No Result
View All Result
IAG
No Result
View All Result

COVID-19 vaccine could be available by October after “world first” facility in Beijing granted production approval

Newsdesk by Newsdesk
Sun 9 Aug 2020 at 11:09
COVID-19 vaccine could be available by October after “world first” facility in Beijing granted production approval
327
SHARES
4.5k
VIEWS
Print Friendly, PDF & Email

China could make available the world’s first COVID-19 vaccine as early as October after the state-run China National Biotec Group (CNBG) announced that a vaccine production facility passed national examination.

According to a report in The Global Times, the facility, located in Beijing, was granted a production certificate following a recent thorough biosecurity examination, meaning it has now been approved to start large scale production once a COVID-19 vaccine is ready. It is described as the “first and largest of its kind” in the world and has the ability to produce 220 million doses of vaccine annually.

Experts now believe the first doses could be produced and made available as early as October give that a number of domestically made candidate vaccines have already entered Phase III trials.

Among them is a vaccine developed by Chinese pharmaceutical company Sinopharm, which is currently testing its candidate on 15,000 volunteers in the United Arab Emirates and preparing to launch a similar trial in Brazil.

Germany’s BioNTech, working in partnership with Shanghai Fosun Pharmaceutical, announced last week that it is has dosed 72 trial participants with a vaccine using mRNA technology – a method which prompts the human body to create its own infection-fighting medicine.

As reported extensively by Inside Asian Gaming last week, a team working out of the Faculty of Medicine at Macau University of Science and Technology (MUST), in collaboration with scientists from mainland China and Hong Kong, have made their own potentially game changing breakthrough, announcing that a vaccine developed using certain residues found in the Spike protein receptor-binding domain (S-RBD) – which is what the COVID-19 virus uses to engage with the cells of the host and cause infection – induced a “potent functional antibody response” in immunized mice, rabbits and monkeys.

These antibodies effectively blocked S-RBD from binding with the host cell receptor as it does in cases of infection, therefore neutralizing the virus during laboratory studies.

Any vaccine produced out of the newly approved Beijing facility would first be used locally, primarily on medical staff and those working at border checkpoints, however the timeline is notable given that most candidate vaccines have targeted early 2021 for release.

“It is possible that China could have a COVID-19 vaccine as early as the end of October as some domestically made COVID-19 vaccines have entered phase three clinical trials and need about a month to observe their effects on samples,” Shanghai-based vaccine researcher Tao Lina told The Global Times.

There are reportedly 13 Chinese companies currently working on the development of COVID-19 vaccines of which nine have been approved for clinical trials.

RelatedPosts

Thai committee to submit report on legalized casinos in May

Thai tourism sector worried Beijing may restrict Chinese visitation if casinos legalized

Wed 26 Mar 2025 at 16:59
South Korea drops quarantine requirement for unvaccinated arrivals

South Korea to introduce visa exemption for tour groups from China

Sun 23 Mar 2025 at 18:34
China says Myanmar scam parks have been largely eliminated

China says Myanmar scam parks have been largely eliminated

Sat 8 Mar 2025 at 08:44
Macau quarantines all travelers arriving from specific areas in Shanghai and Tianjin

China expects GDP to grow by 5% this year

Thu 6 Mar 2025 at 05:57
Load More
Tags: ChinaChina National Biotec Groupcovid-19Faculty of Medicine at Macau University of Science and TechnologyProduction facilityThe Global TimesVaccination
Share218Share13
Newsdesk

Newsdesk

The IAG Newsdesk team comprises some of the most experienced journalists in the Asian gaming industry. Offering a broad range of expertise, their decades of combined know-how spans multiple countries across a variety of topics.

Current Issue

Editorial – Knife’s edge

Editorial – Knife’s edge

by Andrew W Scott and Ben Blaschke
Tue 29 Apr 2025 at 15:14

Thailand’s Entertainment Complex journey is at a critical point, with the success or failure of the initiative to be determined...

The changing face of Macau

The changing face of Macau

by Ben Blaschke
Tue 29 Apr 2025 at 15:09

Inside Asian Gaming takes a deep dive into the new, post-COVID Macau where a revenue environment that seems to be...

Born again

Born again

by Pierce Chan
Tue 29 Apr 2025 at 14:47

Premiering in September 2010 at City of Dreams, The House of Dancing Water was a visionary creation by artistic maestro...

Richard Howarth – Testing the limits

Richard Howarth – Testing the limits

by Ben Blaschke
Tue 29 Apr 2025 at 13:17

Richard Howarth, Chief Business Officer APAC for global testing laboratory GLI, discusses his career journey and his passion for fast-paced...

Evolution Asia
Aristocrat
GLI
Mindslot
Solaire
Hann
Tecnet
Nustar
Jumbo

Related Posts

Japan Credit Rating Agency affirms Konami’s A+ rating due to “high earning capacity”

Stability in Australia, North America drives 7.4% revenue growth for Konami’s gaming segment in FY25

by Newsdesk
Fri 9 May 2025 at 06:48

Global gaming supplier Konami reported a 7.4% increase in revenue in its Gaming & Systems segment to JPY42.7 billion in the year ended 31 March 2025, with operating profit up by 16.3% to JPY7.3 billion, according to financial statements published...

MGM’s Hornbuckle bullish on “unique” Macau as China stimulus uncertainty sees gaming stocks dive

MGM’s Bill Hornbuckle extends employment contract through end-2028

by Ben Blaschke
Fri 9 May 2025 at 06:34

MGM Resorts CEO and President Bill Hornbuckle has renewed his employment contract with the company through to the end of 2028, after which time he will assume an advisory role to assist with the pre-opening phase of its US$9 billion...

Winds of change

Melco says working with potential buyers on bidding process for City of Dreams Manila

by Ben Blaschke
Fri 9 May 2025 at 06:16

Melco Resorts & Entertainment said Thursday that it is currently in discussions with potential buyers of its stake in Philippines integrated resort City of Dreams Manila and will soon have a shortlist of interested parties that will partake in a...

Melco prices US$750 million Senior Notes offering

Melco smashes revenue and profit estimates in 1Q25, gains market share on powerful performance of Macau resorts

by Ben Blaschke
Fri 9 May 2025 at 05:36

An impressively strong performance in Macau was enough to see Melco Resorts & Entertainment comfortably beat consensus in 1Q25, with the company reporting a 10.8% year-on-year increase in total operating revenues to US$1.23 billion including a 12.2% rise in gaming...



IAG

© 2005-2024
Inside Asian Gaming.
All rights reserved.

  • SUBSCRIBE FREE
  • NEWSFEED
  • MAG ARTICLES
  • VIDEO
  • OPINION
  • TAGS
  • REGIONAL
  • EVENTS
  • CONSULTING
  • CONTRIBUTORS
  • MAGAZINES
  • ABOUT
  • CONTACT
  • ADVERTISE
  • 中文
  • 日本語

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In

Add New Playlist

No Result
View All Result
  • 中文
  • 日本語
  • Subscribe
  • Newsfeed
  • Mag Articles
  • Video
  • Opinion
  • Tags
  • Regional
  • Events
  • Contributors
  • Magazines
  • Advertise
  • Contact
  • About
  • Home for G2E Asia

© 2005-2024
Inside Asian Gaming.
All rights reserved.

  • 中文
  • English
  • 日本語